In this episode we explore the slightly less common acute leukaemia sub-type, Acute Lymphoblastic Leukaemia (ALL). Prof Adele Fielding takes us through many technical questions, why is ALL a disease seen predominantly in the young, why does it require years of maintenance therapy unlike AML, how is it diagnosed and graded, can ALL be considered a lymphoma in some patients, the role of the Philadelphia chromosome in an era of TKIs, and many more.
This discussion is kept very grounded in the experience of the patient and their family throughout, and we delve into the communication challenges that must be negotiated by healthcare professionals when caring for patients with acute haematological conditions.
